Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of FBLG will decline by -10.91% over the next 2 Weeks and hit $0.23 by Friday, January 2, 2026. In that time frame, FBLG's share price is expected to range between $0.19 and $0.27.
BearishAverageBullishFBLG shares fell -2.79% in Monday, December 22, 2025's trading session, dropping from a previous close of $0.26 to move at $0.25. The stock demonstrated notable intraday movement (see FBLG's key stats for a full breakdown), fluctuating between $0.25 and $0.28, a +12.09% trading range. While recent weeks have seen some volatility, FBLG has managed to secure a -4.70% drop over the past 2 weeks. The downward price movement was accompanied by decreased trading volume, with approximately 1.45M shares changing hands, 796.92K fewer than the previous session. This amounted to $365.08K in total market activity.
Will FBLG Continue Its Upward Trend?
According to analyst ratings and projections for FBLG, FibroBiologics, Inc. Common Stock shares are anticipated to increase by +7.66%, potentially reaching $0.27 per share by January 2, 2026. Short-term technical indicators currently suggest a neutral sentiment for FBLG. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 18 positive trading days within the past 30 sessions. Based on the FBLG stock forecast, now is a good time to buy FBLG stock because its current trading price is +9.12% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on FBLG covering social and institutional perspectives.
FBLG Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into FBLG's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 41.21% to 41.67%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 41.61%, suggests a neutral medium-term outlook. Meanwhile, the 100-day RSI, at 76.30%, indicates a bearish outlook for the long term. Insights into FBLG's shareholder base show how institutional investors are positioning themselves during these momentum shifts
FibroBiologics Common Stock Short-Term Forecasts
FBLG Forecast For Next 5 Days
Our algorithm anticipates FibroBiologics Common Stock (FBLG) stock could hit $0.24 by Dec 29, 2025. This represents a -3.86% fall from today's price, following a -25.65% change over the past five days.
FBLG Forecast For Next 30 Days
Based on analysis of market trends, the outlook for FibroBiologics, Inc. Common Stock (FBLG) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.21, which would mean a -16.43% decrease from the current price of $0.25. Projections for this period range from a high of $0.30 to a low of $0.11.
FBLG Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for FibroBiologics Common Stock's price over the next three months point to a rise. FBLG stock is expected to peak at $0.89 on Jan 05, 2026 before potentially dipping to $0.00 on Mar 20, 2026. On average, FBLG is likely to trade around $0.35 in the coming 90 days.
FibroBiologics Common Stock Stock Forecast 2025
Based on our predictive models, FibroBiologics Common Stock (FBLG) is expected to trade between $0.14 and $0.78 throughout 2025. This would result in an average price of $0.45, potentially offering investors a +79.07% return from current levels.
FibroBiologics, Inc. Common Stock Monthly Forecast 2025–2026
December 2025
According to our latest forecast models, FibroBiologics, Inc. Common Stock (FBLG) is positioned to show a strong performance in December 2025. The price is predicted to move between $0.14 and $0.78, settling at an average of $0.45. This could translate to a +79.07% gain.
January 2026
Based on current market signals, FibroBiologics, Inc. Common Stock is projected to trend january 2026. We forecast a trading range from $0.16 to $0.89, with a likely average price of $0.53. Investors could expect a potential return of +110.90%.
February 2026
Our predictive algorithms indicate FibroBiologics, Inc. Common Stock stock may see a shift in February 2026. The expected range spans $0.00–$0.62, with an average target of $0.24. This represents a cautious outlook and a possible loss of -4.50%.
March 2026
Analyzing established trends, FibroBiologics, Inc. Common Stock looks set to move in March 2026. Projections place the stock between $0.00 and $0.47, averaging around $0.17. This suggests a -32.35% loss from current levels.
April 2026
Market indicators suggest FibroBiologics, Inc. Common Stock could experience notable changes during April 2026. Prices could fluctuate within $0.00 to $0.44, with a midpoint forecast of $0.13. The stock might deliver a -48.27% loss.
May 2026
Forecasting for May 2026, models estimate that FibroBiologics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.49, averaging $0.21. This signals a cautious trajectory with potential returns around -16.43%.
June 2026
According to our latest forecast models, FibroBiologics, Inc. Common Stock (FBLG) is positioned to show a strong performance in June 2026. The price is predicted to move between $0.00 and $0.54, settling at an average of $0.16. This could translate to a -36.33% loss.
July 2026
Based on current market signals, FibroBiologics, Inc. Common Stock is projected to trend july 2026. We forecast a trading range from $0.00 to $0.49, with a likely average price of $0.18. Investors could expect a potential return of -28.37%.
August 2026
Our predictive algorithms indicate FibroBiologics, Inc. Common Stock stock may see a shift in August 2026. The expected range spans $0.00–$0.41, with an average target of $0.07. This represents a cautious outlook and a possible loss of -72.14%.
September 2026
Analyzing established trends, FibroBiologics, Inc. Common Stock looks set to move in September 2026. Projections place the stock between $0.00 and $0.39, averaging around $0.08. This suggests a -68.17% loss from current levels.
October 2026
Market indicators suggest FibroBiologics, Inc. Common Stock could experience notable changes during October 2026. Prices could fluctuate within $0.00 to $0.38, with a midpoint forecast of $0.09. The stock might deliver a -64.19% loss.
November 2026
Forecasting for November 2026, models estimate that FibroBiologics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.33, averaging $0.09. This signals a cautious trajectory with potential returns around -64.19%.
December 2026
According to our latest forecast models, FibroBiologics, Inc. Common Stock (FBLG) is positioned to show a strong performance in December 2026. The price is predicted to move between $0.00 and $0.40, settling at an average of $0.10. This could translate to a -60.21% loss.
FBLG's history of dividends and stock splits also plays a role in long-term investor confidence.

